BALDWIN BROTHERS LLC/MA - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 41 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
BALDWIN BROTHERS LLC/MA ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$6,145
+7.2%
5000.0%0.00%0.0%
Q4 2022$5,730
+186.5%
5000.0%0.00%
Q3 2022$2,000
-33.3%
5000.0%0.00%
Q2 2022$3,0000.0%5000.0%0.00%
Q1 2022$3,000
+50.0%
5000.0%0.00%
Q4 2021$2,0000.0%5000.0%0.00%
Q3 2021$2,000
-33.3%
5000.0%0.00%
Q2 2021$3,0000.0%5000.0%0.00%
Q1 2021$3,0000.0%5000.0%0.00%
Q4 2020$3,000
+50.0%
5000.0%0.00%
Q3 2020$2,0000.0%5000.0%0.00%
Q2 2020$2,000
+100.0%
5000.0%0.00%
Q1 2020$1,000
-50.0%
5000.0%0.00%
Q4 2019$2,0000.0%5000.0%0.00%
Q3 2019$2,000
-33.3%
5000.0%0.00%
Q2 2019$3,0000.0%5000.0%0.00%
Q1 2019$3,000
+50.0%
5000.0%0.00%
Q4 2018$2,000
-33.3%
5000.0%0.00%
Q3 2018$3,000
+50.0%
5000.0%0.00%
Q2 2018$2,000
-50.0%
5000.0%0.00%
-100.0%
Q1 2018$4,0005000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders